Press Releases - 2020-06-04

Date	Title	Company
04-Jun-2020	Stilla Technologies presents a novel approach for COVID-19 testing combining group testing with digital PCR and publishes the largest comparative study to date for group testing of SARS-CoV-2	Stilla Technologies
04-Jun-2020	Press Launch of hVIVO COVID Clear Test, the most accurate antibody test available to UK employers to help get people back to work	hVIVO
04-Jun-2020	ENHERTU® (Trastuzumab Deruxtecan) Achieved a Tumour Response Rate of 45.3% (95% CI, 70.2%-91.9%) in Patients with HER2 Positive Metastatic Colorectal Cancer in Phase 2 DESTINY-CRC01 Trial1	AstraZeneca
04-Jun-2020	NHS App Integrates eConsult for Online Consultations	NHS
04-Jun-2020	VIVEbiotech collaborates with Xyphos Biosciences for clinical development support of convertibleCAR-T(TM) cell therapy	Astellas Pharma Inc
04-Jun-2020	AbbVie at EULAR \| New Long-term Data from RINVOQ™ (upadacitinib, 15 mg) Phase 3 Studies in Rheumatoid Arthritis	AbbVie
04-Jun-2020	Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma	Genmab A/S
04-Jun-2020	Elixirgen Therapeutics Concludes pre-IND Meeting with FDA for its COVID-19 Vaccine Candidate EXG-5003	Elixirgen Therapeutics, Inc.
04-Jun-2020	Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy	Artax Biopharma
04-Jun-2020	Novadoz Pharmaceuticals FDA Approvals of Oseltamivir and Dofetilide Continues the Company's Rise in the Generic Market	Novadoz Pharmaceuticals
04-Jun-2020	Evolugate Takes Up the Challenge of Boosting Host Cells Used to Manufacture COVID-19 Vaccines	Evolugate, LLC
04-Jun-2020	INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea	INOVIO Pharmaceuticals, Inc.
04-Jun-2020	B.R.A.I.N. Biotechnology Research and Information Network AG has successfully completed cash capital increase from authorised capital; placement price set at EUR 8.30 per new share	B.R.A.I.N. Biotechnology Research And Information Network AG
04-Jun-2020	Labmed: Singapore's LABMED shipped over 20 million masks to meet global demand	Labmed
04-Jun-2020	Immunovia Intends to Carry Out a Directed Share Issue Through an Accelerated Book Building Process	Immunovia AB
04-Jun-2020	Targovax Enters Collaboration With Leidos to add Checkpoint Inhibitor Functionality to ONCOS Viruses	Targovax
04-Jun-2020	Medios AG successfully completes capital increase with gross proceeds of approximately €53m	Medios AG
04-Jun-2020	Press Launch of hVIVO COVID Clear Test, the Most Accurate Antibody Test Available to UK Employers to Help Get People Back to Work	Open Orphan
04-Jun-2020	Press Launch of hVIVO COVID Clear Test, the Most Accurate Antibody Test Available to UK Employers to Help Get People Back to Work	Open Orphan
04-Jun-2020	Hollister Biosciences Inc. Subsidiary AlphaMind Brands Inc. Plans to Launch Initial Medicinal Mushroom Based Product Line	Hollister Biosciences Inc.